HomeCompareRENB vs O

RENB vs O: Dividend Comparison 2026

RENB yields 140.85% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RENB wins by $18.19M in total portfolio value
10 years
RENB
RENB
● Live price
140.85%
Share price
$1.42
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.23M
Annual income
$7,605,007.88
Full RENB calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — RENB vs O

📍 RENB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRENBO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RENB + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RENB pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RENB
Annual income on $10K today (after 15% tax)
$11,971.83/yr
After 10yr DRIP, annual income (after tax)
$6,464,256.70/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, RENB beats the other by $6,459,919.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RENB + O for your $10,000?

RENB: 50%O: 50%
100% O50/50100% RENB
Portfolio after 10yr
$9.13M
Annual income
$3,805,055.31/yr
Blended yield
41.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

RENB
No analyst data
Altman Z
-174.5
Piotroski
3/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RENB buys
0
O buys
0
No recent congressional trades found for RENB or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRENBO
Forward yield140.85%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$18.23M$34.2K
Annual income after 10y$7,605,007.88$5,102.74
Total dividends collected$16.79M$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: RENB vs O ($10,000, DRIP)

YearRENB PortfolioRENB Income/yrO PortfolioO Income/yrGap
1← crossover$24,785$14,084.51$10,818$608.16+$14.0KRENB
2$59,143$32,624.07$11,787$741.68+$47.4KRENB
3$136,042$72,758.05$12,946$911.00+$123.1KRENB
4$301,974$156,409.10$14,345$1,127.94+$287.6KRENB
5$647,582$324,470.73$16,056$1,409.05+$631.5KRENB
6$1,343,219$650,306.15$18,171$1,777.83+$1.33MRENB
7$2,697,870$1,260,625.08$20,820$2,268.21+$2.68MRENB
8$5,253,056$2,366,334.87$24,188$2,929.90+$5.23MRENB
9$9,926,863$4,306,093.23$28,533$3,837.11+$9.90MRENB
10$18,226,751$7,605,007.88$34,235$5,102.74+$18.19MRENB

RENB vs O: Complete Analysis 2026

RENBStock

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Full RENB Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this RENB vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RENB vs SCHDRENB vs JEPIRENB vs KORENB vs MAINRENB vs STAGRENB vs ADCRENB vs NNNRENB vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.